Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 1266 entries
Sorted by: Best Match Show Resources per page
Telmisartan reduced abdominal circumference and body weight with decreasing triglyceride level in patients with type 2 diabetes and metabolic syndrome.

Obesity research & clinical practice

Kakuma T, Gotoh K, Masaki T, Itateyama E, Abe N, Yoshimatsu H.
PMID: 24345653
Obes Res Clin Pract. 2010 Apr-Jun;4(2):e83-e162. doi: 10.1016/j.orcp.2009.12.003.

SUMMARY: Telmisartan has the dual ability to inhibit angiotensin II type 1 receptors and activate peroxisome proliferator-activated receptor gamma (PPAR), especially as a selective PPAR modulator that does not strongly promote adipogenesis for weight gain. Accordingly, Telmisartan is expected...

Cite
Kakuma T, Gotoh K, Masaki T, et al. Telmisartan reduced abdominal circumference and body weight with decreasing triglyceride level in patients with type 2 diabetes and metabolic syndrome. Obes Res Clin Pract. 2010;4(2):e83-e162doi: 10.1016/j.orcp.2009.12.003.
Kakuma, T., Gotoh, K., Masaki, T., Itateyama, E., Abe, N., & Yoshimatsu, H. (2010). Telmisartan reduced abdominal circumference and body weight with decreasing triglyceride level in patients with type 2 diabetes and metabolic syndrome. Obesity research & clinical practice, 4(2), e83-e162. https://doi.org/10.1016/j.orcp.2009.12.003
Kakuma, Tetsuya, et al. "Telmisartan reduced abdominal circumference and body weight with decreasing triglyceride level in patients with type 2 diabetes and metabolic syndrome." Obesity research & clinical practice vol. 4,2 (2010): e83-e162. doi: https://doi.org/10.1016/j.orcp.2009.12.003
Kakuma T, Gotoh K, Masaki T, Itateyama E, Abe N, Yoshimatsu H. Telmisartan reduced abdominal circumference and body weight with decreasing triglyceride level in patients with type 2 diabetes and metabolic syndrome. Obes Res Clin Pract. 2010 Apr-Jun;4(2):e83-e162. doi: 10.1016/j.orcp.2009.12.003. PMID: 24345653.
Copy Download .nbib Format: NLM
Two-step hepatic artery reconstruction for a hepatic artery lacking in length for the use of a microclamp in living donor liver transplantation.

International journal of surgery case reports

Okochi M, Kenjo A, Asai E, Ueda K, Gotoh M.
PMID: 27203819
Int J Surg Case Rep. 2016;24:70-2. doi: 10.1016/j.ijscr.2016.04.032. Epub 2016 Apr 20.

INTRODUCTION: We describe successful two-step hepatic artery reconstruction in a patient whose graft site hepatic artery was too short for the use of a microclamp in living donor liver transplantation.PRESENTATION OF CASE: A 57-year-old woman was diagnosed as having...

Cite
Okochi M, Kenjo A, Asai E, et al. Two-step hepatic artery reconstruction for a hepatic artery lacking in length for the use of a microclamp in living donor liver transplantation. Int J Surg Case Rep. 2016;24:70-2doi: 10.1016/j.ijscr.2016.04.032.
Okochi, M., Kenjo, A., Asai, E., Ueda, K., & Gotoh, M. (2016). Two-step hepatic artery reconstruction for a hepatic artery lacking in length for the use of a microclamp in living donor liver transplantation. International journal of surgery case reports, 2470-2. https://doi.org/10.1016/j.ijscr.2016.04.032
Okochi, Masayuki, et al. "Two-step hepatic artery reconstruction for a hepatic artery lacking in length for the use of a microclamp in living donor liver transplantation." International journal of surgery case reports vol. 24 (2016): 70-2. doi: https://doi.org/10.1016/j.ijscr.2016.04.032
Okochi M, Kenjo A, Asai E, Ueda K, Gotoh M. Two-step hepatic artery reconstruction for a hepatic artery lacking in length for the use of a microclamp in living donor liver transplantation. Int J Surg Case Rep. 2016;24:70-2. doi: 10.1016/j.ijscr.2016.04.032. Epub 2016 Apr 20. PMID: 27203819; PMCID: PMC4885017.
Copy Download .nbib Format: NLM
Prognostic value of peripheral and local forkhead box P3.

Molecular and clinical oncology

Hasegawa T, Suzuki H, Yamaura T, Muto S, Okabe N, Osugi J, Hoshino M, Higuchi M, Ise K, Gotoh M.
PMID: 25054031
Mol Clin Oncol. 2014 Sep;2(5):685-694. doi: 10.3892/mco.2014.299. Epub 2014 May 29.

Several types of immunosuppressive mechanisms in cancer patients have been reported to date. Regulatory T cells (Tregs), which express the master control transcription factor forkhead box P3 (FoxP3), are considered to play a major role in hampering antitumor immune...

Cite
Hasegawa T, Suzuki H, Yamaura T, et al. Prognostic value of peripheral and local forkhead box P3. Mol Clin Oncol. 2014;2(5):685-694doi: 10.3892/mco.2014.299.
Hasegawa, T., Suzuki, H., Yamaura, T., Muto, S., Okabe, N., Osugi, J., Hoshino, M., Higuchi, M., Ise, K., & Gotoh, M. (2014). Prognostic value of peripheral and local forkhead box P3. Molecular and clinical oncology, 2(5), 685-694. https://doi.org/10.3892/mco.2014.299
Hasegawa, Takeo, et al. "Prognostic value of peripheral and local forkhead box P3." Molecular and clinical oncology vol. 2,5 (2014): 685-694. doi: https://doi.org/10.3892/mco.2014.299
Hasegawa T, Suzuki H, Yamaura T, Muto S, Okabe N, Osugi J, Hoshino M, Higuchi M, Ise K, Gotoh M. Prognostic value of peripheral and local forkhead box P3. Mol Clin Oncol. 2014 Sep;2(5):685-694. doi: 10.3892/mco.2014.299. Epub 2014 May 29. PMID: 25054031; PMCID: PMC4106667.
Copy Download .nbib Format: NLM
Age-Related Changes in Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR1) and Receptor 2 (sVEGFR2) in Healthy Japanese Subjects.

Indian journal of clinical biochemistry : IJCB

Okamoto Y, Mita T, Kodama T, Gotoh Y, Fujita N, Fukui T, Masuzawa T.
PMID: 26089624
Indian J Clin Biochem. 2015 Jul;30(3):351-6. doi: 10.1007/s12291-014-0463-z. Epub 2014 Oct 10.

We measured serum soluble vascular endothelial growth factor receptor 1 (sVEGFR1) and receptor 2 (sVEGFR2) levels in healthy Japanese individuals in order to establish a reference value using a specific ELISA. Significant differences were observed in serum sVEGFR1 and...

Cite
Okamoto Y, Mita T, Kodama T, et al. Age-Related Changes in Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR1) and Receptor 2 (sVEGFR2) in Healthy Japanese Subjects. Indian J Clin Biochem. 2014;30(3):351-6doi: 10.1007/s12291-014-0463-z.
Okamoto, Y., Mita, T., Kodama, T., Gotoh, Y., Fujita, N., Fukui, T., & Masuzawa, T. (2015). Age-Related Changes in Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR1) and Receptor 2 (sVEGFR2) in Healthy Japanese Subjects. Indian journal of clinical biochemistry : IJCB, 30(3), 351-6. https://doi.org/10.1007/s12291-014-0463-z
Okamoto, Yoshihiro, et al. "Age-Related Changes in Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR1) and Receptor 2 (sVEGFR2) in Healthy Japanese Subjects." Indian journal of clinical biochemistry : IJCB vol. 30,3 (2015): 351-6. doi: https://doi.org/10.1007/s12291-014-0463-z
Okamoto Y, Mita T, Kodama T, Gotoh Y, Fujita N, Fukui T, Masuzawa T. Age-Related Changes in Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR1) and Receptor 2 (sVEGFR2) in Healthy Japanese Subjects. Indian J Clin Biochem. 2015 Jul;30(3):351-6. doi: 10.1007/s12291-014-0463-z. Epub 2014 Oct 10. PMID: 26089624; PMCID: PMC4469059.
Copy Download .nbib Format: NLM
Surgical resection and inferior vena cava reconstruction for treatment of the malignant tumor: technical success and outcomes.

Annals of vascular diseases

Goto H, Hashimoto M, Akamatsu D, Shimizu T, Miyama N, Tsuchida K, Tajima Y, Ohuchi N.
PMID: 24995055
Ann Vasc Dis. 2014;7(2):120-6. doi: 10.3400/avd.oa.13-00125. Epub 2014 Mar 15.

OBJECTIVE: The purpose of this study was to review patients who underwent inferior vena cava (IVC) resection with concomitant malignant tumor resection and to consider the operative procedures and the outcomes.MATERIALS AND METHODS: Between 2000 and 2012, 41 patients...

Cite
Goto H, Hashimoto M, Akamatsu D, et al. Surgical resection and inferior vena cava reconstruction for treatment of the malignant tumor: technical success and outcomes. Ann Vasc Dis. 2014;7(2):120-6doi: 10.3400/avd.oa.13-00125.
Goto, H., Hashimoto, M., Akamatsu, D., Shimizu, T., Miyama, N., Tsuchida, K., Tajima, Y., & Ohuchi, N. (2014). Surgical resection and inferior vena cava reconstruction for treatment of the malignant tumor: technical success and outcomes. Annals of vascular diseases, 7(2), 120-6. https://doi.org/10.3400/avd.oa.13-00125
Goto, Hitoshi, et al. "Surgical resection and inferior vena cava reconstruction for treatment of the malignant tumor: technical success and outcomes." Annals of vascular diseases vol. 7,2 (2014): 120-6. doi: https://doi.org/10.3400/avd.oa.13-00125
Goto H, Hashimoto M, Akamatsu D, Shimizu T, Miyama N, Tsuchida K, Tajima Y, Ohuchi N. Surgical resection and inferior vena cava reconstruction for treatment of the malignant tumor: technical success and outcomes. Ann Vasc Dis. 2014;7(2):120-6. doi: 10.3400/avd.oa.13-00125. Epub 2014 Mar 15. PMID: 24995055; PMCID: PMC4072859.
Copy Download .nbib Format: NLM
Prepro-TRH 178-199 inhibits histamine- or restraint stress-induced activation of corticotropin releasing hormone production in rat hypothalamus.

Obesity research & clinical practice

Fukagawa T, Fukagawa K, Gotoh K, Noguchi H, Yoshimatsu H.
PMID: 24351449
Obes Res Clin Pract. 2007 May;1(2):I-II. doi: 10.1016/j.orcp.2007.01.002.

Under restraint stress conditions, prepro-thyrotropin releasing hormone (TRH) 178-199 suppresses adrenocorticotropic hormone (ACTH) secretion from the rat pituitary, which indicates that prepro-TRH 178-199 is a candidate endogenous corticotropin releasing inhibitory factor (CRIF). Restraint stress also activates the release of...

Cite
Fukagawa T, Fukagawa K, Gotoh K, et al. Prepro-TRH 178-199 inhibits histamine- or restraint stress-induced activation of corticotropin releasing hormone production in rat hypothalamus. Obes Res Clin Pract. 2007;1(2):I-IIdoi: 10.1016/j.orcp.2007.01.002.
Fukagawa, T., Fukagawa, K., Gotoh, K., Noguchi, H., & Yoshimatsu, H. (2007). Prepro-TRH 178-199 inhibits histamine- or restraint stress-induced activation of corticotropin releasing hormone production in rat hypothalamus. Obesity research & clinical practice, 1(2), I-II. https://doi.org/10.1016/j.orcp.2007.01.002
Fukagawa, Tomiyo, et al. "Prepro-TRH 178-199 inhibits histamine- or restraint stress-induced activation of corticotropin releasing hormone production in rat hypothalamus." Obesity research & clinical practice vol. 1,2 (2007): I-II. doi: https://doi.org/10.1016/j.orcp.2007.01.002
Fukagawa T, Fukagawa K, Gotoh K, Noguchi H, Yoshimatsu H. Prepro-TRH 178-199 inhibits histamine- or restraint stress-induced activation of corticotropin releasing hormone production in rat hypothalamus. Obes Res Clin Pract. 2007 May;1(2):I-II. doi: 10.1016/j.orcp.2007.01.002. PMID: 24351449.
Copy Download .nbib Format: NLM
Symptoms Predictive for Efficacy of Naftopidil in Patients with Benign Prostate Hyperplasia.

Lower urinary tract symptoms

Funahashi Y, Hattori R, Yoshino Y, Matsukawa Y, Sassa N, Gotoh M.
PMID: 26676397
Low Urin Tract Symptoms. 2011 Sep;3(2):113-7. doi: 10.1111/j.1757-5672.2011.00097.x. Epub 2011 Jun 28.

OBJECTIVES: To evaluate the lower urinary tract symptoms predicting the efficacy of the α1-adrenoreceptor (AR) antagonist naftopidil in patients with benign prostate hyperplasia.METHODS: The efficacy of naftopidil was examined on the basis of changes in the international prostate symptom...

Cite
Funahashi Y, Hattori R, Yoshino Y, et al. Symptoms Predictive for Efficacy of Naftopidil in Patients with Benign Prostate Hyperplasia. Low Urin Tract Symptoms. 2011;3(2):113-7doi: 10.1111/j.1757-5672.2011.00097.x.
Funahashi, Y., Hattori, R., Yoshino, Y., Matsukawa, Y., Sassa, N., & Gotoh, M. (2011). Symptoms Predictive for Efficacy of Naftopidil in Patients with Benign Prostate Hyperplasia. Lower urinary tract symptoms, 3(2), 113-7. https://doi.org/10.1111/j.1757-5672.2011.00097.x
Funahashi, Yasuhito, et al. "Symptoms Predictive for Efficacy of Naftopidil in Patients with Benign Prostate Hyperplasia." Lower urinary tract symptoms vol. 3,2 (2011): 113-7. doi: https://doi.org/10.1111/j.1757-5672.2011.00097.x
Funahashi Y, Hattori R, Yoshino Y, Matsukawa Y, Sassa N, Gotoh M. Symptoms Predictive for Efficacy of Naftopidil in Patients with Benign Prostate Hyperplasia. Low Urin Tract Symptoms. 2011 Sep;3(2):113-7. doi: 10.1111/j.1757-5672.2011.00097.x. Epub 2011 Jun 28. PMID: 26676397.
Copy Download .nbib Format: NLM
Tuning the polarity of charge transport in InSb nanowires via heat treatment.

Nanotechnology

Hnida KE, Bäβler S, Akinsinde L, Gooth J, Nielsch K, Socha RP, Łaszcz A, Czerwinski A, Sulka GD.
PMID: 26112309
Nanotechnology. 2015 Jul 17;26(28):285701. doi: 10.1088/0957-4484/26/28/285701. Epub 2015 Jun 26.

InSb nanowire (NW) arrays were prepared by pulsed electrodeposition combined with a porous template technique. The resulting polycrystalline material has a stoichiometric composition (In:Sb = 1:1) and a high length-to-diameter ratio. Based on a combination of Fourier transform infrared...

Cite
Hnida KE, Bäβler S, Akinsinde L, et al. Tuning the polarity of charge transport in InSb nanowires via heat treatment. Nanotechnology. 2015;26(28):285701doi: 10.1088/0957-4484/26/28/285701.
Hnida, K. E., Bäβler, S., Akinsinde, L., Gooth, J., Nielsch, K., Socha, R. P., Łaszcz, A., Czerwinski, A., & Sulka, G. D. (2015). Tuning the polarity of charge transport in InSb nanowires via heat treatment. Nanotechnology, 26(28), 285701. https://doi.org/10.1088/0957-4484/26/28/285701
Hnida, Katarzyna E, et al. "Tuning the polarity of charge transport in InSb nanowires via heat treatment." Nanotechnology vol. 26,28 (2015): 285701. doi: https://doi.org/10.1088/0957-4484/26/28/285701
Hnida KE, Bäβler S, Akinsinde L, Gooth J, Nielsch K, Socha RP, Łaszcz A, Czerwinski A, Sulka GD. Tuning the polarity of charge transport in InSb nanowires via heat treatment. Nanotechnology. 2015 Jul 17;26(28):285701. doi: 10.1088/0957-4484/26/28/285701. Epub 2015 Jun 26. PMID: 26112309.
Copy Download .nbib Format: NLM
Severe respiratory failure due to co-infection with human metapneumovirus and Streptococcus pneumoniae.

Respiratory medicine case reports

Seki M, Yoshida H, Gotoh K, Hamada N, Motooka D, Nakamura S, Yamamoto N, Hamaguchi S, Akeda Y, Watanabe H, Iida T, Tomono K.
PMID: 26029528
Respir Med Case Rep. 2014 Mar 15;12:13-5. doi: 10.1016/j.rmcr.2013.12.007. eCollection 2014.

A 64-year-old male patient was admitted with respiratory failure, although chest X-rays revealed only mild bronchiolitis. Streptococcus pneumoniae, which usually presents as massive lobular pneumonia, was isolated from sputum, however, pan-pathogen screening using a next-generation sequencer also detected human...

Cite
Seki M, Yoshida H, Gotoh K, et al. Severe respiratory failure due to co-infection with human metapneumovirus and Streptococcus pneumoniae. Respir Med Case Rep. 2014;12:13-5doi: 10.1016/j.rmcr.2013.12.007.
Seki, M., Yoshida, H., Gotoh, K., Hamada, N., Motooka, D., Nakamura, S., Yamamoto, N., Hamaguchi, S., Akeda, Y., Watanabe, H., Iida, T., & Tomono, K. (2014). Severe respiratory failure due to co-infection with human metapneumovirus and Streptococcus pneumoniae. Respiratory medicine case reports, 1213-5. https://doi.org/10.1016/j.rmcr.2013.12.007
Seki, Masafumi, et al. "Severe respiratory failure due to co-infection with human metapneumovirus and Streptococcus pneumoniae." Respiratory medicine case reports vol. 12 (2014): 13-5. doi: https://doi.org/10.1016/j.rmcr.2013.12.007
Seki M, Yoshida H, Gotoh K, Hamada N, Motooka D, Nakamura S, Yamamoto N, Hamaguchi S, Akeda Y, Watanabe H, Iida T, Tomono K. Severe respiratory failure due to co-infection with human metapneumovirus and Streptococcus pneumoniae. Respir Med Case Rep. 2014 Mar 15;12:13-5. doi: 10.1016/j.rmcr.2013.12.007. eCollection 2014. PMID: 26029528; PMCID: PMC4061431.
Copy Download .nbib Format: NLM
Structure of intermediate phase II of LiNH2 under high pressure.

The journal of physical chemistry. B

Yamawaki H, Fujihisa H, Gotoh Y, Nakano S.
PMID: 25081245
J Phys Chem B. 2014 Aug 21;118(33):9991-6. doi: 10.1021/jp505133q. Epub 2014 Aug 08.

A new intermediate phase (phase II) was found between phases I and III in LiNH2 in the pressure range of 10 to 13 GPa through the analysis of infrared and powder X-ray diffraction measurements to 25 GPa at room...

Cite
Yamawaki H, Fujihisa H, Gotoh Y, et al. Structure of intermediate phase II of LiNH2 under high pressure. J Phys Chem B. 2014;118(33):9991-6doi: 10.1021/jp505133q.
Yamawaki, H., Fujihisa, H., Gotoh, Y., & Nakano, S. (2014). Structure of intermediate phase II of LiNH2 under high pressure. The journal of physical chemistry. B, 118(33), 9991-6. https://doi.org/10.1021/jp505133q
Yamawaki, Hiroshi, et al. "Structure of intermediate phase II of LiNH2 under high pressure." The journal of physical chemistry. B vol. 118,33 (2014): 9991-6. doi: https://doi.org/10.1021/jp505133q
Yamawaki H, Fujihisa H, Gotoh Y, Nakano S. Structure of intermediate phase II of LiNH2 under high pressure. J Phys Chem B. 2014 Aug 21;118(33):9991-6. doi: 10.1021/jp505133q. Epub 2014 Aug 08. PMID: 25081245.
Copy Download .nbib Format: NLM
Evaluation of performance of the Omni mode for detecting video capsule endoscopy images: A multicenter randomized controlled trial.

Endoscopy international open

Hosoe N, Watanabe K, Miyazaki T, Shimatani M, Wakamatsu T, Okazaki K, Esaki M, Matsumoto T, Abe T, Kanai T, Ohtsuka K, Watanabe M, Ikeda K, Tajiri H, Ohmiya N, Nakamura M, Goto H, Tsujikawa T, Ogata H.
PMID: 27540577
Endosc Int Open. 2016 Aug;4(8):E878-82. doi: 10.1055/s-0042-111389. Epub 2016 Aug 08.

BACKGROUND AND STUDY AIMS: Olympus recently developed a new algorithm called Omni mode that discards redundant video capsule endoscopy (VCE) images. The current study aimed to demonstrate the non-inferiority of the Omni mode in terms of true positives (TPs)...

Cite
Hosoe N, Watanabe K, Miyazaki T, et al. Evaluation of performance of the Omni mode for detecting video capsule endoscopy images: A multicenter randomized controlled trial. Endosc Int Open. 2016;4(8):E878-82doi: 10.1055/s-0042-111389.
Hosoe, N., Watanabe, K., Miyazaki, T., Shimatani, M., Wakamatsu, T., Okazaki, K., Esaki, M., Matsumoto, T., Abe, T., Kanai, T., Ohtsuka, K., Watanabe, M., Ikeda, K., Tajiri, H., Ohmiya, N., Nakamura, M., Goto, H., Tsujikawa, T., & Ogata, H. (2016). Evaluation of performance of the Omni mode for detecting video capsule endoscopy images: A multicenter randomized controlled trial. Endoscopy international open, 4(8), E878-82. https://doi.org/10.1055/s-0042-111389
Hosoe, Naoki, et al. "Evaluation of performance of the Omni mode for detecting video capsule endoscopy images: A multicenter randomized controlled trial." Endoscopy international open vol. 4,8 (2016): E878-82. doi: https://doi.org/10.1055/s-0042-111389
Hosoe N, Watanabe K, Miyazaki T, Shimatani M, Wakamatsu T, Okazaki K, Esaki M, Matsumoto T, Abe T, Kanai T, Ohtsuka K, Watanabe M, Ikeda K, Tajiri H, Ohmiya N, Nakamura M, Goto H, Tsujikawa T, Ogata H. Evaluation of performance of the Omni mode for detecting video capsule endoscopy images: A multicenter randomized controlled trial. Endosc Int Open. 2016 Aug;4(8):E878-82. doi: 10.1055/s-0042-111389. Epub 2016 Aug 08. PMID: 27540577; PMCID: PMC4988834.
Copy Download .nbib Format: NLM
Partial lipodystrophy in patients who have undergone hematopoietic stem cell transplantation during childhood: an institutional cross-sectional survey.

Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology

Adachi M, Oto Y, Muroya K, Hanakawa J, Asakura Y, Goto H.
PMID: 28458462
Clin Pediatr Endocrinol. 2017;26(2):99-108. doi: 10.1297/cpe.26.99. Epub 2017 Apr 22.

Partial lipodystrophy (PD), a condition similar to metabolic syndrome without obesity, is one of the late complications of hematopoietic stem cell transplantation (HSCT) performed during childhood. We aimed to investigate the prevalence and risk factors of PD. A cross-sectional...

Cite
Adachi M, Oto Y, Muroya K, et al. Partial lipodystrophy in patients who have undergone hematopoietic stem cell transplantation during childhood: an institutional cross-sectional survey. Clin Pediatr Endocrinol. 2017;26(2):99-108doi: 10.1297/cpe.26.99.
Adachi, M., Oto, Y., Muroya, K., Hanakawa, J., Asakura, Y., & Goto, H. (2017). Partial lipodystrophy in patients who have undergone hematopoietic stem cell transplantation during childhood: an institutional cross-sectional survey. Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology, 26(2), 99-108. https://doi.org/10.1297/cpe.26.99
Adachi, Masanori, et al. "Partial lipodystrophy in patients who have undergone hematopoietic stem cell transplantation during childhood: an institutional cross-sectional survey." Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology vol. 26,2 (2017): 99-108. doi: https://doi.org/10.1297/cpe.26.99
Adachi M, Oto Y, Muroya K, Hanakawa J, Asakura Y, Goto H. Partial lipodystrophy in patients who have undergone hematopoietic stem cell transplantation during childhood: an institutional cross-sectional survey. Clin Pediatr Endocrinol. 2017;26(2):99-108. doi: 10.1297/cpe.26.99. Epub 2017 Apr 22. PMID: 28458462; PMCID: PMC5402311.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 1266 entries